Trademark: 87419171
Status Date
Monday, June 8, 2020
Filing Date
Thursday, April 20, 2017
Published for Opposition
Tuesday, August 29, 2017
Abandoned Date
Monday, June 8, 2020
5 Pharmaceutical preparations for the treatment of neurological, orthopedic, musculoskeletal, and/or inflammatory conditions, diseases and disorders; anti-inflammatory and analgesic preparations
The wording "ALMIDANZ" has no meaning in a foreign language.
Jun 8, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 8, 2020
Abandonment - No Use Statement Filed
Sep 26, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 24, 2019
Extension 4 Granted
Sep 24, 2019
Extension 4 Filed
Sep 24, 2019
Teas Extension Received
Jul 8, 2019
Assigned To Examiner
Apr 17, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2019
Extension 3 Granted
Apr 15, 2019
Extension 3 Filed
Apr 15, 2019
Teas Extension Received
Oct 9, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 5, 2018
Extension 2 Granted
Oct 5, 2018
Extension 2 Filed
Oct 5, 2018
Teas Extension Received
Apr 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2018
Extension 1 Granted
Apr 5, 2018
Extension 1 Filed
Apr 5, 2018
Teas Extension Received
Oct 24, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 29, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 29, 2017
Published For Opposition
Aug 9, 2017
Notification Of Notice Of Publication E-Mailed
Jul 27, 2017
Law Office Publication Review Completed
Jul 25, 2017
Assigned To Lie
Jul 7, 2017
Approved For Pub - Principal Register
Jul 7, 2017
Examiner's Amendment Entered
Jul 7, 2017
Notification Of Examiners Amendment E-Mailed
Jul 7, 2017
Examiners Amendment E-Mailed
Jul 7, 2017
Examiners Amendment -Written
Jul 4, 2017
Assigned To Examiner
Apr 26, 2017
New Application Office Supplied Data Entered In Tram
Apr 24, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
